Gender disparity in a large nonreferral-based cohort of hypertrophic cardiomyopathy patients

Journal of Women's Health

Volumn 17, Issue 10, 2008, Pages 1629-1634

  Brimacombe, M ^a,c   Walter, D ^b   Salberg, L ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Hypertrophic Cardiomyopathy Association   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; DIZZINESS; DRUG USE; FAMILY HISTORY; FATIGUE; FEMALE; HEALTH SURVEY; HEART PALPITATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT INFORMATION; PRIORITY JOURNAL; REFERENCE DATABASE; SELF REPORT; SEX DIFFERENCE; THORAX PAIN;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENTS; POPULATION GROUPS; SEX DISTRIBUTION; SEX FACTORS; UNITED STATES; WOMEN'S HEALTH; WORLD HEALTH;

EID: 57349086441     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0734     Document Type: Article

References (9)

1. Maron BJ, Salberg L. Hypertrophic cardiomyopathy: For patients, their families and interested physicians. New York: Blackwell Publishing, 2006.
2. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow obstruction. Circulation 2006;114:2232-2239.
3. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881-1891.
4. Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol 2003;42:882-888.
5. Maron BJ, Estes NAM, Maron MS, Almquist AK, Link MS, Udelson JE. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 2003;107:2872-2875.
6. Maron BJ, Olivetto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation 2000;102:858-864.
7. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardiomyopathy. Circulation 2006;113:858-862.
8. Olivotto I, Maron MS, Adabag AS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;46:480-487.
9. Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111:472-479.